328 Views · 97 Downloads · ★★★★★ 5.0

Simvastatin repurposing towards endometriosis management: The use of self -nanoemulsifying drug delivery system

PUBLISHED April 28, 2023 (DOI: https://doi.org/10.54985/peeref.2304p6131285)



Payel Chakraborty1 , Tamilvanan Shunmugaperumal1
  1. NIPER, Guwahati

Conference / event

International Symposium on Recent Trends and Future Opportunities in Pharmaceuticals, November 2022 (Virtual)

Poster summary

Simvastatin is having pleiotropic effects. This current study aimed to manage endometriosis by repurposing simvastatin into self-nanoemulsifying drug delivery system. RP-HPLC method was developed and validated for simvastatin followed by solubility study in oils, surfactants, and co-surfactants. The vehicles showing the highest solubility for simvastatin were used for creating pseudo-ternary phase diagram to obtain the concentration range for a stable emulsion. Formulation optimization was done systemically by formulation by design approach (FbD) which includes the Ishikawa fishbone diagram as one of the initial risk assessment parameters.


Self-nanoemulsifying drug delivery system, Simvastatin, Endometriosis, Ishikawa fishbone diagram

Research areas

Pharmacy and Pharmacology


  1. Jing YS, Ma YF, Pan FB, Li MS, Zheng YG, Wu LF, Zhang DS. An insight into antihyperlipidemic effects of polysaccharides from natural resources. Molecules. 2022 Mar 15;27(6):1903.
  2. Sokalska A, Cress A, Bruner-Tran KL, Osteen KG, Taylor HS, Ortega I, Duleba AJ. Simvastatin decreases invasiveness of human endometrial stromal cells. Biology of reproduction. 2012 Jul 1;87(1):2-1.
  3. Wong JC, Fiscus RR. Resveratrol at anti-angiogenesis/anticancer concentrations suppresses protein kinase G signaling and decreases IAPs expression in HUVECs. Anticancer research. 2015 Jan 1;35(1):273-81.


No data provided

Supplemental files

  1. Supporting Information about Self Nanoemulsifying Drug Delivery Systems   Download
  2. Self Nanoemulsifying Drug Delivery Systems preparation   Download

Additional information

Competing interests
No competing interests were disclosed.
Data availability statement
The datasets generated during and / or analyzed during the current study are available from the corresponding author on reasonable request.
Creative Commons license
Copyright © 2023 Chakraborty et al. This is an open access work distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Chakraborty, P., Shunmugaperumal, T. Simvastatin repurposing towards endometriosis management: The use of self -nanoemulsifying drug delivery system [not peer reviewed]. Peeref 2023 (poster).
Copy citation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started